COVID-19 & Oral Oncolytics

Apr 14, 2020

On this mini-podcast, ​we explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.

 

Guest: Lauren J. Sanders, PharmD, MTM Oncology Clinical Pharmacist, Oral Antineoplastics Program, The University of Arizona Cancer Center

 

Related Content:
​ 

• ACCC COVID-19 Resource Center
• COVID-19 & Oral Oncolytics Transcript
• Oncology Pharmacy Education Network
• Integrating Oral Oncolytics into Pharmacy Practice
• “The Emerging Role of Oral Oncolytics,” by Ali McBride, PharmD, MS, BCOP
• “The Role of the Oral Oncology Nurse Navigator,” by Mary K. Anderson, BSN, RN, OCN, et al.

 

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.